Amyotrophic Lateral Sclerosis Registry in Thailand
ConditionALS (Amyotrophic Lateral Sclerosis)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorChulalongkorn University
About this trial
This is a prospective, observational, multicenter registry designed to collect comprehensive clinical, genetic, and outcome data from patients diagnosed with amyotrophic lateral sclerosis (ALS) across Thailand. The registry will establish a national dataset to describe epidemiology, clinical presentation, progression, and treatment outcomes, and will serve as a platform for future clinical and translational research.
Eligibility criteria
Qualifiers
Diagnosis of ALS according to El Escorial or Gold Coast criteria
Age ≥ 18 years
Ability and willingness to provide informed consent
Disqualifiers
Patients unwilling to provide informed consent
Patients with alternative diagnoses mimicking ALS
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov